NCT06711120 Comparative Analysis of Radiofrequency Ablation and Microwave Ablation Procedures for the Treatment of Small Saphenous Varicose Veins
| NCT ID | NCT06711120 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chengdu University of Traditional Chinese Medicine |
| Condition | Varicose Veins of Lower Limb |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2024-12-01 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2024-12-01 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Objective: To investigate the clinical efficacy of ultrasound-guided radiofrequency ablation and microwave ablation in the treatment of primary saphenous varicose veins.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years and ≤90 years; * Clinical diagnosis of primary varicose veins of the lower extremities, CEAP clinical classification C2-C6, requiring treatment of the great and/or small saphenous vein segments, and at least 1 of the clinical symptoms of swelling, pain, burning sensation, heaviness, easy fatigue, itchy skin, and night cramps; * Valve insufficiency of the great saphenous vein, small saphenous vein, or transport vein; * Doppler ultrasound confirmation of a saphenous vein diameter greater than 3 mm and less than 12 mm in the standing position; * Only one limb per patient was selected for inclusion in the study; * Patients signed an informed consent form and were willing to co-operate in completing the protocol-specified investigations and follow-up visits. Exclusion Criteria: * Thrombosis of the great saphenous or small saphenous vein, or combined deep vein thrombosis, or previous history of deep vein thrombosis or pulmonary embolism. * Recurrent varicose veins after previous treatment. * Severe distortion of the great saphenous vein with anticipated catheter failure. * Severe lower limb ischaemia (CLI) (ABPI \<0.8). * Known allergy to medications and device materials involved in the study. * Pre-existing implanted pacemaker, defibrillator, currently on regular anticoagulation therapy (e.g., warfarin, heparin). * Women who are pregnant or breastfeeding. * Unable or unwilling to complete the questionnaire. * Participating in a study of another drug or device. * Life expectancy \<1 year. * Those undergoing treatment for skin malignancies other than non-melanoma. * Daily use of narcotic drugs or non-steroidal anti-inflammatory drugs to control pain due to venous disease. * In the judgement of the investigator, endovenous therapy is not appropriate.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06711120 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Varicose Veins of Lower Limb. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06711120 currently recruiting?
Yes, NCT06711120 is actively recruiting participants. Contact the research team at Chunshuihe@msn.com for enrollment information.
Where is the NCT06711120 trial being conducted?
This trial is being conducted at Chengdu, China.
Who is sponsoring the NCT06711120 clinical trial?
NCT06711120 is sponsored by Chengdu University of Traditional Chinese Medicine. The trial plans to enroll 150 participants.